ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Internal Medicine

Top Internal Medicine Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
KENNETH RICE MD

Internal Medicine

51,864

$3.64M

1661
1236 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

25%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$70
Average prescription price

Avg: $67

LUIS ARANGO M.D

Internal Medicine

45,010

$4.18M

1468
1101 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$93
Average prescription price

Avg: $67

SIEGFRIED KREIS M.D.

Internal Medicine

44,200

$2.75M

890
734 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

32%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$62
Average prescription price

Avg: $67

JORGE BARBOZA SOSA M.D.

Internal Medicine

43,516

$2.4M

1066
900 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

21%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 27%

$55
Average prescription price

Avg: $67

SALEH JAAFAR MD

Internal Medicine

41,200

$3.15M

2119
1563 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 27%

$76
Average prescription price

Avg: $67

HAITHAM JIFI BAHLOOL MD

Internal Medicine

39,414

$2.46M

1360
1039 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

27%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 27%

$63
Average prescription price

Avg: $67

ANTONIO RUIZ M.D.

Internal Medicine

37,320

$2.62M

842
458 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

14%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$70
Average prescription price

Avg: $67

LAILA HIRJEE M.D.

Internal Medicine

36,791

$2.23M

848
808 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

20%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$61
Average prescription price

Avg: $67

MIGUEL MOLINAS M.D.

Internal Medicine

36,385

$2.4M

928
762 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

26%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 27%

$66
Average prescription price

Avg: $67

ROGER KISER MD

Internal Medicine

35,952

$2.13M

832
699 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

38%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$59
Average prescription price

Avg: $67

KOJO POBEE MD

Internal Medicine

35,911

$2.07M

717
644 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

33%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 27%

$58
Average prescription price

Avg: $67

RAMON PINEDA M.D.

Internal Medicine

35,087

$1.53M

1165
944 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 27%

$44
Average prescription price

Avg: $67

MUHAMMED AZIZ M.D.

Internal Medicine

34,776

$1.61M

1404
1023 are 65+

1%
patients receiving schedule two controlled substances

Avg: 1%

22%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$46
Average prescription price

Avg: $67

WILLIAM GEORGE M.D.

Internal Medicine

34,277

$2.04M

795
681 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

21%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$59
Average prescription price

Avg: $67

CHRISTOPHER LOCKHART M.D.

Internal Medicine

34,128

$2.12M

834
700 are 65+

8%
patients receiving schedule two controlled substances

Avg: 1%

31%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$62
Average prescription price

Avg: $67

VAQAR DAR MD

Internal Medicine

33,587

$1.76M

854
758 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

26%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$52
Average prescription price

Avg: $67

NAJMUDDIN KARIMJEE M.D.

Internal Medicine

32,929

$2M

2014
1250 are 65+

1%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$61
Average prescription price

Avg: $67

RUBEN DE LOS SANTOS MD PA

Internal Medicine

32,391

$2.08M

1041
835 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 27%

$64
Average prescription price

Avg: $67

CARLOS CASAS M.D.

Internal Medicine

32,277

$2.25M

842
689 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 27%

$70
Average prescription price

Avg: $67

SYED ANWAR M.D.

Internal Medicine

32,195

$1.62M

1461
1143 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

20%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$50
Average prescription price

Avg: $67

JEROME LEE SANG MD

Internal Medicine

32,089

$1.87M

1039
880 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

24%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$58
Average prescription price

Avg: $67

BRYAN WHITE M.D.

Internal Medicine

31,975

$1.84M

607
538 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

27%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$58
Average prescription price

Avg: $67

MICHAEL ROMAIN MD

Internal Medicine

31,839

$1.93M

800
710 are 65+

8%
patients receiving schedule two controlled substances

Avg: 1%

25%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$61
Average prescription price

Avg: $67

JOSE BARAHONA M.D.

Internal Medicine

31,694

$2.93M

1258
926 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

31%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

37%
prescriptions for brand name drugs

Avg: 27%

$92
Average prescription price

Avg: $67

ALBERT DALLEY MD

Internal Medicine

29,527

$1.51M

1009
812 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

23%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$51
Average prescription price

Avg: $67

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank